The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19
- PMID: 32383737
- PMCID: PMC7239225
- DOI: 10.1093/ehjcvp/pvaa048
The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19
Comment on
-
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27. J Thromb Haemost. 2020. PMID: 32220112 Free PMC article.
-
Chest CT Features of COVID-19 in Rome, Italy.Radiology. 2020 Aug;296(2):E79-E85. doi: 10.1148/radiol.2020201237. Epub 2020 Apr 3. Radiology. 2020. PMID: 32243238 Free PMC article.
References
-
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–1062. - PMC - PubMed
-
- Liverpool Drug Interactions Group. University of Liverpool (Charts updated 9 April 2020). https://www.covid19-druginteractions.org.
-
- Liedtke MD, Rathbun RC.. Warfarin—antiretroviral interactions. Ann Pharmacother 2009;43:322–328. - PubMed